...
首页> 外文期刊>Biomedical materials >Injectable osteogenic and angiogenic nanocomposite hydrogels for irregular bone defects
【24h】

Injectable osteogenic and angiogenic nanocomposite hydrogels for irregular bone defects

机译:可注射的成骨和血管生成纳米复合水凝胶,用于治疗不规则的骨缺损

获取原文
获取原文并翻译 | 示例
           

摘要

Injectable hydrogels with their 3D structure and good moldability serve as excellent scaffolding material for regenerating irregular non load-bearing bone defects. Most of the bone defects do not heal completely due to the lack of vasculature required for the transport of nutrients and oxygen to the regenerating tissues. To enhance vasculature, we developed an injectable hydrogel system made of chitin and poly (butylene succinate) (PBSu) loaded with 250 +/- 20 nm sized fibrin nanoparticles (FNPs) and magnesium-doped bioglass (MBG). FNPs were expected to enhance vascularisation and MBG was expected to help induce early osteogenesis. Composite hydrogels were analysed using Fourier transform infra-red spectroscopy, scanning electron microscopy (SEM), energy dispersive x-ray spectroscopy, and rheology. Hydrogels with MBG showed a slightly rougher morphology upon SEM analysis. Composites containing 5% MBG and 2% FNPs showed good rheological properties, injectability, temperature stability, biomineralization and protein adsorption. Human umbilical vein endothelial cells (HUVECs) and rabbit-adipose derived mesenchymal stem cells (rASCs) were used for cyto-compatibility studies. Composite gels with 2% FNPs and 2% MBG (composite 1) were considered to be non-toxic to both the cells and were taken for further in vitro studies. Aortic ring assay was carried out to study the angiogenic potential of the hydrogels. The aorta placed with composite hydrogels showed enhanced sprouting of blood vessels. rASCs too showed good spreading on the composite hydrogels. Hydrogels containing MBG showed early initiation of differentiation and higher expression of alkaline phosphatase and osteocalcin confirming the osteoinductive property of MBG. These studies indicate that this composite hydrogel can be used for regenerating irregular bone defects.
机译:具有3D结构和良好成型性的可注射水凝胶可作为出色的脚手架材料,用于再生不规则的非承重骨缺损。由于缺乏营养物质和氧气向再生组织的运输所需的脉管系统,大多数骨缺损无法完全治愈。为了增强脉管系统,我们开发了由几丁质和聚丁二酸丁二酯(PBSu)制成的可注射水凝胶系统,其中装有250 +/- 20 nm的纤维蛋白纳米颗粒(FNP)和掺镁生物玻璃(MBG)。预计FNP可增强血管生成,而MBG则有助于诱导早期成骨。使用傅立叶变换红外光谱,扫描电子显微镜(SEM),能量色散X射线光谱和流变学对复合水凝胶进行了分析。具有MBG的水凝胶在SEM分析时显示出稍微粗糙的形态。含有5%MBG和2%FNP的复合材料表现出良好的流变性,可注射性,温度稳定性,生物矿化和蛋白质吸附。人脐静脉内皮细胞(HUVEC)和兔脂肪来源的间充质干细胞(rASC)用于细胞相容性研究。具有2%FNP和2%MBG(复合物1)的复合凝胶被认为对两种细胞均无毒,并被用于进一步的体外研究。进行主动脉环测定以研究水凝胶的血管生成潜力。放置有复合水凝胶的主动脉显示出增强的血管发芽。 rASC在复合水凝胶上也显示出良好的铺展性。含有MBG的水凝胶显示出分化的早期开始,并且碱性磷酸酶和骨钙素的表达更高,证实了MBG的骨诱导特性。这些研究表明,这种复合水凝胶可用于再生不规则的骨缺损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号